Prostate Cancer News

In the first outside report on its flawed prostate-cancer program, the Philadelphia VA Medical Center was cited for eight apparent violations in using radioactive materials on nearly 100 veterans, federal inspectors have concluded.

Biotechnology company Dendreon said Friday that the Food and Drug Administration will make a regulatory decision on the potential prostate... Biotechnology company Dendreon said Friday that the Food and Drug Administration will make a regulatory decision on the potential prostate cancer vaccine Provenge by May 1. The drug is aimed at treating ...

New research suggests it may become possible for pre-pubescent boys stricken by cancer to prepare for the future when they may be infertile but still want to become natural fathers.

Dendreon Corporation today announced that the FDA provided written acknowledgement that the Company's amended Biologics License Application for PROVENGE is a complete response.

Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is the result of a combined effort.

A new study from researchers at Memorial Sloan-Kettering Cancer Center has found that the majority of surgeons treating prostate cancer in the United States have extremely low annual caseloads, potentially leading to increased rates of both surgical complications and cancer recurrence.

Bay Area researchers are using a new test to help determine whether a patient should be treated for prostate cancer.

Abnormal mammogram: understanding false-positives An abnormal mammogram result can be scary, but in many cases it's a false alarm.

In light of recent reports raising new questions about prostate screenings and treatments, I decided to share again some basic information that may be found to be helpful.

Synta Pharmaceuticals Corp. , a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of ...

Men with advanced prostate cancer could be treated by new drugs being tested in Belfast.

Sir Andrew Lloyd Webber poses in front of the winners' boards with the award for Outstanding Achievement in Music at the Classical Brit Awards 2008 at the Royal Albert Hall on May 8, 2008 in London, England.

Lying in bed one night in 2007, Peter Criss felt something strange: a small lump on his left breast.

On one side are women's health organizations, doctors and breast cancer survivors who stand by the status quo - annual mammograms starting at age 40.

In the article, Dr. Otis Brawley, chief medical officer of the ACS, responded to a study in the current issue of the Journal of the American Medical Association.

IsoRay Inc. a medical isotope company focusing on the treatment of prostate, lung, head and neck and other malignant disease through the use of its proprietary radioisotope technology, announced its financial results for the first quarter of fiscal year 2010, ended September 30, 2009.

Former state Senate President Pro Tem and 2010 Oakland mayoral candidate Don Perata joined cancer research and health advocates Monday to launch a ballot measure that would hike cigarette taxes by a dollar a pack.

Taking a watch and wait approach to prostate cancer, rather than attempting to remove the cancer, is a safe approach and doesn't lead to more deaths, concludes a new analysis.

Main Category: Prostate / Prostate Cancer Also Included In: Urology / Nephrology ; Cancer / Oncology Article Date: 16 Nov 2009 - 4:00 PST UroToday.com - Gonadotrophin-releasing hormone agonists are currently the 'standard of care' for androgen deprivation therapy in prostate cancer .

Besides its ability to function as a transcription factor, experimental observations suggest that AR becomes a licensing factor for DNA replication in AS prostate cancer cells and thus must be degraded during each cell cycle in these cells to allow reinitiation of DNA replication in the next cell cycle.